-+ 0.00%
-+ 0.00%
-+ 0.00%

APREA THERAPEUTICS TO PROVIDE CLINICAL UPDATE ON ACESOT-1051 PHASE 1 TRIAL EVALUATING WEE1 INHIBITOR, APR-1051, AT ASCO 2026 ANNUAL MEETING

Reuters·04/21/2026 14:15:00

Please log in to view news